Assessment of Radiology Modalities in Detecting and Diagnosing Parathyroid Disorders: A Retrospective Study

ORIGINAL ARTICLE
Shaimaa Alattas, Sara Alsaiari, Leen Albalbeesi, Saeed Bafaraj, Ahmed Abduljabbar, Shoaa Shetewi, Bander Al Mutairi, Haifa Alnahdi, Maryam Abuhathrah

 
For citation: Alattas S, Alsaiari S, Albalbeesi L, Bafaraj S, Abduljabbar A, Shetewi S, Al Mutairi B, Alnahdi H, Abuhathrah M. Assessment of Radiology Modalities in Detecting and Diagnosing Parathyroid Disorders: A Retrospective Study. International Journal of Biomedicine. 2025;15(2):364-370. doi:10.21103/Article15(2)_OA15
 
Originally published June 5, 2025
 

Abstract: 

Background: Parathyroid disorders can be part of a complex syndrome or endocrine disorder. Radiological models help diagnose parathyroid disorders. The current study aims to assess the sensitivity, specificity, and accuracy of radiology modalities in examining parathyroid disorders.  
Methods and Results: A cross-sectional retrospective study was performed using clinical data records (2012 to 2023) of patients complaining of parathyroid disorders at King Abdul-Aziz University Hospital in Saudi Arabia. Diagnoses were performed by SPECT, CT, ultrasound, and a bone mineral density (BMD) test. The study results displayed SPECT, CT, and BMD to attain the highest level of sensitivity, omitting unresponsive patients with low specificity. Previous literature reviews showed little or no correlation with most study findings. However, none of the previous studies included BMD as a beneficial radiological model in diagnosing parathyroid disorder.  
Conclusion: The unique and promising results obtained from the BMD model in this study suggest that future researchers should focus on applications of BMD to detect parathyroid disorder. This could lead to developing refined diagnostic protocols and treatment strategies, potentially improving patient outcomes. 

Keywords: 
parathyroid diseases • sensitivity • specificity • tomography
References: 
  1. Leung EKY. Parathyroid hormone. Adv Clin Chem. 2021;101:41-93. doi: 10.1016/bs.acc.2020.06.005. Epub 2020 Jul 20. PMID: 33706890.
  2. Noussios G, Anagnostis P, Natsis K. Ectopic parathyroid glands and their anatomical, clinical and surgical implications. Exp Clin Endocrinol Diabetes. 2012 Nov;120(10):604-10. doi: 10.1055/s-0032-1327628. Epub 2012 Nov 22. PMID: 23174995.
  3. Mi J, Fang Y, Xian J, Wang G, Guo Y, Hong H, Chi M, Li YF, He P, Gao J, Liao W. Comparative Effectiveness of MRI, 4D-CT and Ultrasonography in Patients with Secondary Hyperparathyroidism. Ther Clin Risk Manag. 2023 May 2;19:369-381. doi: 10.2147/TCRM.S379814. PMID: 37159605; PMCID: PMC10163888.
  4. Wu C, Zhu B, Kang S, Wang S, Liu Y, Mei X, Zhang H, Jiang S. Ultrasound characteristics of normal parathyroid glands and analysis of the factors affecting their display. BMC Med Imaging. 2024 Feb 13;24(1):42. doi: 10.1186/s12880-024-01214-7. PMID: 38350842; PMCID: PMC10863184.
  5. Hiramitsu T, Hasegawa Y, Futamura K, Okada M, Goto N, Narumi S, Watarai Y, Tominaga Y, Ichimori T. Treatment for secondary hyperparathyroidism focusing on parathyroidectomy. Front Endocrinol (Lausanne). 2023 Apr 20;14:1169793. doi: 10.3389/fendo.2023.1169793. PMID: 37152972; PMCID: PMC10159274.
  6. Sarah B. Characteristics of primary hyperparathyroidism in young adults: a retrospective study [Doctoral dissertation]. Ghent University; 2024.
  7. Özdemir E, Genç M, Aydos U, Polat ŞB, Kandemir Z, Tam AA, Yildirim N, Türkölmez Ş. Comparison of 99mTc-MIBI planar scintigraphy, SPET/CT and ultrasonography in detection of parathyroid adenoma in patients with primary hyperparathyroidism. Hell J Nucl Med. 2020 Jan-Apr;23(1):21-26. doi: 10.1967/s002449912002. Epub 2020 Mar 31. PMID: 32222728.
  8. Zhang R, Zhang Z, Huang P, Li Z, Hu R, Zhang J, Qiu W, Hu P. Diagnostic performance of ultrasonography, dual-phase 99mTc-MIBI scintigraphy, early and delayed 99mTc-MIBI SPECT/CT in preoperative parathyroid gland localization in secondary hyperparathyroidism. BMC Med Imaging. 2020 Aug 3;20(1):91. doi: 10.1186/s12880-020-00490-3. PMID: 32746794; PMCID: PMC7398336.
  9. Yeh R, Tay YD, Tabacco G, Dercle L, Kuo JH, Bandeira L, McManus C, Leung DK, Lee JA, Bilezikian JP. Diagnostic Performance of 4D CT and Sestamibi SPECT/CT in Localizing Parathyroid Adenomas in Primary Hyperparathyroidism. Radiology. 2019 May;291(2):469-476. doi: 10.1148/radiol.2019182122. Epub 2019 Mar 5. PMID: 30835187; PMCID: PMC7440755.
  10. Lu R, Zhao W, Yin L, Guo R, Wei B, Jin M, Zhou X, Zhang C, Lv X. Efficacy of ultrasonography and Tc-99m MIBI SPECT/CT in preoperative localization of parathyroid adenomas causing primary hyperthyroidism. BMC Med Imaging. 2021 May 21;21(1):87. doi: 10.1186/s12880-021-00616-1. PMID: 34020602; PMCID: PMC8139103.
  11. de Jong MC, Jamal K, Morley S, Beale T, Chung T, Jawad S, Hurel S, Simpson H, Srirangalingam U, Baldeweg SE, Rozalén García V, Otero S, Shawky M, Abdel-Aziz TE, Kurzawinski TR. The use of computed tomography as a first-line imaging modality in patients with primary hyperparathyroidism. Hormones (Athens). 2021 Sep;20(3):499-506. doi: 10.1007/s42000-020-00205-x. Epub 2020 May 13. PMID: 32405929.
  12. Suh YJ, Choi JY, Kim SJ, Chun IK, Yun TJ, Lee KE, Kim JH, Cheon GJ, Youn YK. Comparison of 4D CT, ultrasonography, and 99mTc sestamibi SPECT/CT in localizing single-gland primary hyperparathyroidism. Otolaryngol Head Neck Surg. 2015 Mar;152(3):438-43. doi: 10.1177/0194599814562195. Epub 2014 Dec 17. PMID: 25518904.
  13. Yuan LL, Kan Y, Ma DQ, Yang JG. Combined application of ultrasound and SPECT/CT has incremental value in detecting parathyroid tissue in SHPT patients. Diagn Interv Imaging. 2016 Feb;97(2):219-25. doi: 10.1016/j.diii.2015.08.007. Epub 2015 Oct 1. PMID: 26432401.
  14. Kedarisetty S, Fundakowski C, Ramakrishnan K, Dadparvar S. Clinical Value of Tc99m-MIBI SPECT/CT Versus 4D-CT or US in Management of Patients With Hyperparathyroidism. Ear Nose Throat J. 2019 Mar;98(3):149-157. doi: 10.1177/0145561319828668. Epub 2019 Feb 19. PMID: 30938239.
  15. Pogosian K, Karonova T, Ryzhkova D, Yanevskaya L, Tsoy U, Yudina O, Berkovich G, Dalmatova A, Grineva E. 11C-methionine PET/CT and conventional imaging techniques in the diagnosis of primary hyperparathyroidism. Quant Imaging Med Surg. 2023 Apr 1;13(4):2352-2363. doi: 10.21037/qims-22-584. Epub 2023 Feb 16. PMID: 37064353; PMCID: PMC10102764.
  16. Christakis I, Vu T, Chuang HH, Fellman B, Figueroa AMS, Williams MD, Busaidy NL, Perrier ND. The diagnostic accuracy of neck ultrasound, 4D-Computed tomographyand sestamibi imaging in parathyroid carcinoma. Eur J Radiol. 2017 Oct;95:82-88. doi: 10.1016/j.ejrad.2017.07.026. Epub 2017 Aug 1. PMID: 28987702.
  17. Manyalich-Blasi M, Domínguez-Garijo P, Saavedra-Pérez D, Sánchez-Izquierdo N, Casanueva Eliceiry S, Perissinotti A, Mora Porta M, de Hollanda A, Hanzu FA, López-Boado Serrat MA, Rull Ortuño AR, Ardid J, Vidal-Sicart S, Vidal Pérez Ò. Comparison of [18F]fluorocholine PET/CT with [99mTc]sestamibi and ultrasonography to detect parathyroid lesions in primary hyperparathyroidism: a prospective study. Gland Surg. 2022 Nov;11(11):1764-1771. doi: 10.21037/gs-22-198. PMID: 36518798; PMCID: PMC9742049.

Download Article
Received January 22, 2025.
Accepted March 9, 2025.
©2025 International Medical Research and Development Corporation.